首页 > 最新文献

Obstetrical & Gynecological Survey最新文献

英文 中文
A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes. 2型糖尿病患者自动胰岛素输送的随机试验
IF 3.6 4区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1097/OGX.0000000000001463
Yogish C Kudva, Dan Raghinaru, John W Lum, Timothy E Graham, David Liljenquist, Elias K Spanakis, Francisco J Pasquel, Andrew Ahmann, David T Ahn, Grazia Aleppo, Thomas Blevins, Davida Kruger, Sue A Brown, Carol J Levy, Ruth S Weinstock, Devin W Steenkamp, Tamara Spaic, Irl B Hirsch, Frances Broyles, Michael R Rickels, Michael A Tsoukas, Philip Raskin, Betul Hatipoglu, Donna Desjardins, Adrienne N Terry, Lakshmi G Singh, Georgia M Davis, Caleb Schmid, Jelena Kravarusic, Kasey Coyne, Luis Casaubon, Valerie Espinosa, Jaye K Jones, Kathleen Estrada, Samina Afreen, Camilla Levister, Grenye O'Malley, Selina L Liu, Sheryl Marks, Amy J Peleckis, Melissa-Rosina Pasqua, Vanessa Tardio, Corey Kurek, Ryan D Luker, Jade Churchill, Farbod Z Tajrishi, Ariel Dean, Brittany Dennis, Evelyn Fronczyk, Jennifer Perez, Shereen Mukhashen, Jasmeen Dhillon, Aslihan Ipek, Suzan Bzdick, Astrid Atakov Castillo, Marsha Driscoll, Xenia Averkiou, Cornelia V Dalton-Bakes, Adelyn Moore, Lin F Jordan, Amanda Lesniak, Jordan E Pinsker, Ravid Sasson-Katchalski, Tiffany Campos, Charles Spanbauer, Lauren Kanapka, Craig Kollman, Roy W Beck

(Abstracted from N Engl J Med 2025;392:1801-1812) Automated insulin delivery (AID) systems improve outcomes in type 1 diabetes mellitus (T1DM), but their role in type 2 diabetes mellitus (T2DM) remains uncertain due to limited, small, or uncontrolled studies. Many patients achieve glycated hemoglobin (HbA1c) <7% with glucagon-like peptide 1 agonists or sodium-glucose cotransporter 2 inhibitors, but those who do not may benefit from AID.

自动胰岛素输送(AID)系统可改善1型糖尿病(T1DM)的预后,但由于有限、小型或非对照研究,其在2型糖尿病(T2DM)中的作用仍不确定。许多患者达到糖化血红蛋白(HbA1c)
{"title":"A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.","authors":"Yogish C Kudva, Dan Raghinaru, John W Lum, Timothy E Graham, David Liljenquist, Elias K Spanakis, Francisco J Pasquel, Andrew Ahmann, David T Ahn, Grazia Aleppo, Thomas Blevins, Davida Kruger, Sue A Brown, Carol J Levy, Ruth S Weinstock, Devin W Steenkamp, Tamara Spaic, Irl B Hirsch, Frances Broyles, Michael R Rickels, Michael A Tsoukas, Philip Raskin, Betul Hatipoglu, Donna Desjardins, Adrienne N Terry, Lakshmi G Singh, Georgia M Davis, Caleb Schmid, Jelena Kravarusic, Kasey Coyne, Luis Casaubon, Valerie Espinosa, Jaye K Jones, Kathleen Estrada, Samina Afreen, Camilla Levister, Grenye O'Malley, Selina L Liu, Sheryl Marks, Amy J Peleckis, Melissa-Rosina Pasqua, Vanessa Tardio, Corey Kurek, Ryan D Luker, Jade Churchill, Farbod Z Tajrishi, Ariel Dean, Brittany Dennis, Evelyn Fronczyk, Jennifer Perez, Shereen Mukhashen, Jasmeen Dhillon, Aslihan Ipek, Suzan Bzdick, Astrid Atakov Castillo, Marsha Driscoll, Xenia Averkiou, Cornelia V Dalton-Bakes, Adelyn Moore, Lin F Jordan, Amanda Lesniak, Jordan E Pinsker, Ravid Sasson-Katchalski, Tiffany Campos, Charles Spanbauer, Lauren Kanapka, Craig Kollman, Roy W Beck","doi":"10.1097/OGX.0000000000001463","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001463","url":null,"abstract":"<p><p>(Abstracted from N Engl J Med 2025;392:1801-1812) Automated insulin delivery (AID) systems improve outcomes in type 1 diabetes mellitus (T1DM), but their role in type 2 diabetes mellitus (T2DM) remains uncertain due to limited, small, or uncontrolled studies. Many patients achieve glycated hemoglobin (HbA1c) <7% with glucagon-like peptide 1 agonists or sodium-glucose cotransporter 2 inhibitors, but those who do not may benefit from AID.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"681-683"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes. 2型糖尿病患者自动胰岛素输送的随机试验
IF 3.6 4区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1097/OGX.0000000000001463
Yogish C Kudva, Dan Raghinaru, John W Lum, Timothy E Graham, David Liljenquist, Elias K Spanakis, Francisco J Pasquel, Andrew Ahmann, David T Ahn, Grazia Aleppo, Thomas Blevins, Davida Kruger, Sue A Brown, Carol J Levy, Ruth S Weinstock, Devin W Steenkamp, Tamara Spaic, Irl B Hirsch, Frances Broyles, Michael R Rickels, Michael A Tsoukas, Philip Raskin, Betul Hatipoglu, Donna Desjardins, Adrienne N Terry, Lakshmi G Singh, Georgia M Davis, Caleb Schmid, Jelena Kravarusic, Kasey Coyne, Luis Casaubon, Valerie Espinosa, Jaye K Jones, Kathleen Estrada, Samina Afreen, Camilla Levister, Grenye O'Malley, Selina L Liu, Sheryl Marks, Amy J Peleckis, Melissa-Rosina Pasqua, Vanessa Tardio, Corey Kurek, Ryan D Luker, Jade Churchill, Farbod Z Tajrishi, Ariel Dean, Brittany Dennis, Evelyn Fronczyk, Jennifer Perez, Shereen Mukhashen, Jasmeen Dhillon, Aslihan Ipek, Suzan Bzdick, Astrid Atakov Castillo, Marsha Driscoll, Xenia Averkiou, Cornelia V Dalton-Bakes, Adelyn Moore, Lin F Jordan, Amanda Lesniak, Jordan E Pinsker, Ravid Sasson-Katchalski, Tiffany Campos, Charles Spanbauer, Lauren Kanapka, Craig Kollman, Roy W Beck

(Abstracted from N Engl J Med 2025;392:1801-1812) Automated insulin delivery (AID) systems improve outcomes in type 1 diabetes mellitus (T1DM), but their role in type 2 diabetes mellitus (T2DM) remains uncertain due to limited, small, or uncontrolled studies. Many patients achieve glycated hemoglobin (HbA1c) <7% with glucagon-like peptide 1 agonists or sodium-glucose cotransporter 2 inhibitors, but those who do not may benefit from AID.

自动胰岛素输送(AID)系统可改善1型糖尿病(T1DM)的预后,但由于有限、小型或非对照研究,其在2型糖尿病(T2DM)中的作用仍不确定。许多患者达到糖化血红蛋白(HbA1c)
{"title":"A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.","authors":"Yogish C Kudva, Dan Raghinaru, John W Lum, Timothy E Graham, David Liljenquist, Elias K Spanakis, Francisco J Pasquel, Andrew Ahmann, David T Ahn, Grazia Aleppo, Thomas Blevins, Davida Kruger, Sue A Brown, Carol J Levy, Ruth S Weinstock, Devin W Steenkamp, Tamara Spaic, Irl B Hirsch, Frances Broyles, Michael R Rickels, Michael A Tsoukas, Philip Raskin, Betul Hatipoglu, Donna Desjardins, Adrienne N Terry, Lakshmi G Singh, Georgia M Davis, Caleb Schmid, Jelena Kravarusic, Kasey Coyne, Luis Casaubon, Valerie Espinosa, Jaye K Jones, Kathleen Estrada, Samina Afreen, Camilla Levister, Grenye O'Malley, Selina L Liu, Sheryl Marks, Amy J Peleckis, Melissa-Rosina Pasqua, Vanessa Tardio, Corey Kurek, Ryan D Luker, Jade Churchill, Farbod Z Tajrishi, Ariel Dean, Brittany Dennis, Evelyn Fronczyk, Jennifer Perez, Shereen Mukhashen, Jasmeen Dhillon, Aslihan Ipek, Suzan Bzdick, Astrid Atakov Castillo, Marsha Driscoll, Xenia Averkiou, Cornelia V Dalton-Bakes, Adelyn Moore, Lin F Jordan, Amanda Lesniak, Jordan E Pinsker, Ravid Sasson-Katchalski, Tiffany Campos, Charles Spanbauer, Lauren Kanapka, Craig Kollman, Roy W Beck","doi":"10.1097/OGX.0000000000001463","DOIUrl":"10.1097/OGX.0000000000001463","url":null,"abstract":"<p><p>(Abstracted from N Engl J Med 2025;392:1801-1812) Automated insulin delivery (AID) systems improve outcomes in type 1 diabetes mellitus (T1DM), but their role in type 2 diabetes mellitus (T2DM) remains uncertain due to limited, small, or uncontrolled studies. Many patients achieve glycated hemoglobin (HbA1c) <7% with glucagon-like peptide 1 agonists or sodium-glucose cotransporter 2 inhibitors, but those who do not may benefit from AID.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"681-683"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prenatal Screening for CMV Primary Infection: A Cost-Utility Model. 巨细胞病毒原发感染的产前筛查:成本-效用模型。
IF 3.6 4区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1097/01.ogx.0001172288.00818.27
Gebrael El Hachem, Christian Renaud, Catherine McCarey, Soren Gantt, Fatima Kakkar, Marc Sab, Thomas G Poder, Isabelle Boucoiran

(Abstracted from BJOG 2025;132:805-815) Approximate 1 in 200 neonates in Canada is born with congenital cytomegalovirus (cCMV). CMV is an infection that can cause neurodevelopmental disability in children, including deafness, visual impairment, or cognitive delay.

(摘自BJOG 2025;132:805-815)在加拿大,大约每200名新生儿中就有1名先天性巨细胞病毒(cCMV)。巨细胞病毒是一种感染,可导致儿童神经发育障碍,包括耳聋、视力障碍或认知迟缓。
{"title":"Prenatal Screening for CMV Primary Infection: A Cost-Utility Model.","authors":"Gebrael El Hachem, Christian Renaud, Catherine McCarey, Soren Gantt, Fatima Kakkar, Marc Sab, Thomas G Poder, Isabelle Boucoiran","doi":"10.1097/01.ogx.0001172288.00818.27","DOIUrl":"10.1097/01.ogx.0001172288.00818.27","url":null,"abstract":"<p><p>(Abstracted from BJOG 2025;132:805-815) Approximate 1 in 200 neonates in Canada is born with congenital cytomegalovirus (cCMV). CMV is an infection that can cause neurodevelopmental disability in children, including deafness, visual impairment, or cognitive delay.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"689-691"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perinatal Outcomes Following Nonadherence to Guideline-Based Screening for Gestational Diabetes: A Population-Based Cohort Study. 不遵守基于指南的妊娠糖尿病筛查后的围产期结局:一项基于人群的队列研究。
IF 3.6 4区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1097/01.ogx.0001172280.42312.99
Elizabeth Nethery, Kelly Pickerill, Luba Butska, Michelle Turner, Jennifer A Hutcheon, Patricia A Janssen, Laura Schummers

(Abstracted from Acta Obstet Gynecol Scand 2025;104:839-849) Gestational diabetes mellitus (GDM), defined as high blood sugar onset in pregnancy, is associated with adverse outcomes and increased long-term maternal diabetes risk. Screening protocols vary internationally, with some countries testing only high-risk pregnancies, but Canada has recommended universal screening since 2003.

(摘自journal of obstetrics gynecology, 2025;104:839-849)妊娠期糖尿病(Gestational diabetes, GDM)是指妊娠期起病的高血糖,与不良结局和母体糖尿病的长期风险增加有关。筛查方案在国际上各不相同,一些国家只检测高危妊娠,但加拿大自2003年以来一直建议进行普遍筛查。
{"title":"Perinatal Outcomes Following Nonadherence to Guideline-Based Screening for Gestational Diabetes: A Population-Based Cohort Study.","authors":"Elizabeth Nethery, Kelly Pickerill, Luba Butska, Michelle Turner, Jennifer A Hutcheon, Patricia A Janssen, Laura Schummers","doi":"10.1097/01.ogx.0001172280.42312.99","DOIUrl":"10.1097/01.ogx.0001172280.42312.99","url":null,"abstract":"<p><p>(Abstracted from Acta Obstet Gynecol Scand 2025;104:839-849) Gestational diabetes mellitus (GDM), defined as high blood sugar onset in pregnancy, is associated with adverse outcomes and increased long-term maternal diabetes risk. Screening protocols vary internationally, with some countries testing only high-risk pregnancies, but Canada has recommended universal screening since 2003.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"683-685"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global Consensus on Interstitial Cystitis/Bladder Pain Syndrome: An Update on Therapeutic Treatments. 间质性膀胱炎/膀胱疼痛综合征的全球共识:治疗方法的最新进展。
IF 3.6 4区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1097/OGX.0000000000001459
Karis Buford, Kenneth M Peters, Claus Riedl, Nagendra Nath Mishra, Wyndaele Jean Jacques, Sandor Lovasz, Rui Almeida Pinto, Lori Birder

(Abstracted from Neurourol Urodyn 2025, doi:10.1002/nau.70106) The chronic condition of bladder pain, pressure, and urinary symptoms without a clear cause is classified as interstitial cystitis or bladder pain syndrome (IC/BPS), and it affects large numbers of individuals globally. Presentation varies, but it can include debilitating pain and significantly decrease quality of life.

(摘自《神经学报》,2025,doi:10.1002/nau。70106)没有明确原因的膀胱疼痛、压力和泌尿系统症状的慢性状况被归类为间质性膀胱炎或膀胱疼痛综合征(IC/BPS),它影响着全球大量的个体。表现各不相同,但可能包括使人衰弱的疼痛和显著降低生活质量。
{"title":"Global Consensus on Interstitial Cystitis/Bladder Pain Syndrome: An Update on Therapeutic Treatments.","authors":"Karis Buford, Kenneth M Peters, Claus Riedl, Nagendra Nath Mishra, Wyndaele Jean Jacques, Sandor Lovasz, Rui Almeida Pinto, Lori Birder","doi":"10.1097/OGX.0000000000001459","DOIUrl":"10.1097/OGX.0000000000001459","url":null,"abstract":"<p><p>(Abstracted from Neurourol Urodyn 2025, doi:10.1002/nau.70106) The chronic condition of bladder pain, pressure, and urinary symptoms without a clear cause is classified as interstitial cystitis or bladder pain syndrome (IC/BPS), and it affects large numbers of individuals globally. Presentation varies, but it can include debilitating pain and significantly decrease quality of life.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"694-696"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Systematic Comparison of Implementation Strategies at Three U.S. Clinic Settings That Expanded Access to Self-administered Injectable Contraception. 一个系统的比较实施策略,在三个美国诊所设置,扩大获得自我管理注射避孕。
IF 3.6 4区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1097/01.ogx.0001172300.43934.90
Jennifer Karlin, Tammy Bennett, Leah Michael, Sally Rafie, Elise D Berlan

(Abstracted from Contraception 2025;149:110972) In the United States, depot medroxyprogesterone acetate (DMPA) is distributed in the subcutaneous (SC) formulation in prefilled, single-dose syringes; this format makes self-administration or administration by someone other than a clinician easy and accessible. This may improve contraceptive access by making the medication more available and not requiring a clinician visit for its administration.

(节选自《避孕2025;149:110972》)在美国,储藏库醋酸甲孕酮(DMPA)以预充单剂量注射器的形式分布在皮下(SC)制剂中;这种形式使自我给药或由临床医生以外的人给药变得容易和容易。这可能通过使药物更容易获得并且不需要临床医生访问来改善避孕方法。
{"title":"A Systematic Comparison of Implementation Strategies at Three U.S. Clinic Settings That Expanded Access to Self-administered Injectable Contraception.","authors":"Jennifer Karlin, Tammy Bennett, Leah Michael, Sally Rafie, Elise D Berlan","doi":"10.1097/01.ogx.0001172300.43934.90","DOIUrl":"https://doi.org/10.1097/01.ogx.0001172300.43934.90","url":null,"abstract":"<p><p>(Abstracted from Contraception 2025;149:110972) In the United States, depot medroxyprogesterone acetate (DMPA) is distributed in the subcutaneous (SC) formulation in prefilled, single-dose syringes; this format makes self-administration or administration by someone other than a clinician easy and accessible. This may improve contraceptive access by making the medication more available and not requiring a clinician visit for its administration.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"699-701"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First Trimester Maternal Folate and Vitamin B12 Concentrations and Their Associations With First-Trimester Placental Growth: The Rotterdam Periconception Cohort. 妊娠早期母体叶酸和维生素B12浓度及其与妊娠早期胎盘生长的关系:鹿特丹围孕期队列
IF 3.6 4区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1097/OGX.0000000000001461
M M Van Vliet, S Schoenmakers, S P Willemsen, K D Sinclair, R P M Steegers-Theunissen

(Abstracted from Hum Reprod 2025 ;40(8):1485-1494) Embryonic development relies heavily on 1-carbon metabolism, which is influenced heavily by folate and vitamin B12. Both placental and embryonic and fetal development are affected, and previous research has shown supplementation with folic acid during early pregnancy reduces the prevalence of neural tube defects; some research has also shown that deficiencies in folate and vitamin B12 may be associated with adverse pregnancy outcomes such as preeclampsia and low birth weight.

(摘自《昆虫生殖学报》2025;40(8):1485-1494)胚胎发育主要依赖于1-碳代谢,叶酸和维生素B12对1-碳代谢的影响很大。胎盘和胚胎以及胎儿的发育都受到影响,先前的研究表明,在怀孕早期补充叶酸可以降低神经管缺陷的患病率;一些研究还表明,叶酸和维生素B12的缺乏可能与不良妊娠结局有关,如先兆子痫和低出生体重。
{"title":"First Trimester Maternal Folate and Vitamin B12 Concentrations and Their Associations With First-Trimester Placental Growth: The Rotterdam Periconception Cohort.","authors":"M M Van Vliet, S Schoenmakers, S P Willemsen, K D Sinclair, R P M Steegers-Theunissen","doi":"10.1097/OGX.0000000000001461","DOIUrl":"10.1097/OGX.0000000000001461","url":null,"abstract":"<p><p>(Abstracted from Hum Reprod 2025 ;40(8):1485-1494) Embryonic development relies heavily on 1-carbon metabolism, which is influenced heavily by folate and vitamin B12. Both placental and embryonic and fetal development are affected, and previous research has shown supplementation with folic acid during early pregnancy reduces the prevalence of neural tube defects; some research has also shown that deficiencies in folate and vitamin B12 may be associated with adverse pregnancy outcomes such as preeclampsia and low birth weight.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"704-706"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1. 慢病毒基因治疗严重白细胞粘附缺陷1型。
IF 3.6 4区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1097/OGX.0000000000001462
Claire Booth, Julián Sevilla, Elena Almarza, Caroline Y Kuo, Josune Zubicaray, Dayna Terrazas, Gráinne O'Toole, Maria Chitty-Lopez, Grace Choi, Eileen Nicoletti, Janel Long-Boyle, Augustine Fernandes, Kritika Chetty, Satiro De Oliveira, Crystal Banuelos, Jinhua Xu-Bayford, Antonella Lucía Bastone, Philipp John-Neek, Connie Jackson, Theodore B Moore, Kimberly Gilmour, Axel Schambach, Michael Rothe, Sanchali Kasbekar, Gayatri R Rao, Kinnari Patel, Gaurav Shah, Adrian J Thrasher, Juan A Bueren, Jonathan D Schwartz, Donald B Kohn

(Abstracted from N Engl J Med 2025;392:1698-1709) Leukocyte adhesion deficiency type I (LAD-I) is an autosomal recessive immune disorder marked by recurrent, life-threatening infections, with 25% to 39% mortality before age 2 years without curative therapy. Common symptoms include umbilical-cord complications, poorly healing cutaneous lesions, persistent leukocytosis, and periodontitis.

(摘要自中华医学杂志2025;392:1698-1709)白细胞粘附缺乏症I型(LAD-I)是一种常染色体隐性免疫疾病,以复发性、危及生命的感染为特征,2岁前未经根治性治疗的死亡率为25%至39%。常见症状包括脐带并发症、愈合不良的皮肤病变、持续的白细胞增多和牙周炎。
{"title":"Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1.","authors":"Claire Booth, Julián Sevilla, Elena Almarza, Caroline Y Kuo, Josune Zubicaray, Dayna Terrazas, Gráinne O'Toole, Maria Chitty-Lopez, Grace Choi, Eileen Nicoletti, Janel Long-Boyle, Augustine Fernandes, Kritika Chetty, Satiro De Oliveira, Crystal Banuelos, Jinhua Xu-Bayford, Antonella Lucía Bastone, Philipp John-Neek, Connie Jackson, Theodore B Moore, Kimberly Gilmour, Axel Schambach, Michael Rothe, Sanchali Kasbekar, Gayatri R Rao, Kinnari Patel, Gaurav Shah, Adrian J Thrasher, Juan A Bueren, Jonathan D Schwartz, Donald B Kohn","doi":"10.1097/OGX.0000000000001462","DOIUrl":"10.1097/OGX.0000000000001462","url":null,"abstract":"<p><p>(Abstracted from N Engl J Med 2025;392:1698-1709) Leukocyte adhesion deficiency type I (LAD-I) is an autosomal recessive immune disorder marked by recurrent, life-threatening infections, with 25% to 39% mortality before age 2 years without curative therapy. Common symptoms include umbilical-cord complications, poorly healing cutaneous lesions, persistent leukocytosis, and periodontitis.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"687-689"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Personalized Prediction of Opioid Demand After Surgery for Pelvic Organ Prolapse: A Randomized Controlled Trial. 盆腔器官脱垂术后阿片类药物需求的个性化预测:一项随机对照试验。
IF 3.6 4区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1097/01.ogx.0001172296.60790.17
Hope H Bauer, Maura A Schlussel, Emily A Hoffberg, Kasey M Palm, Stephen P Rhodes, Susan D Wherley, Margot Le Neveu, Sarah B Sears, Gabriella M Rustia, Adonis K Hijaz, Sangeeta T Mahajan, Anne G Sammarco, David Sheyn

(Abstracted from Obstet Gynecol 2025;146(2):285-292) Prolapse repair is one of the most common surgeries performed in adult women. An overwhelming majority (80%) of individuals who undergo pelvic organ prolapse repair are prescribed opioids postoperatively, and for many individuals, this is their first exposure to these substances.

(摘自《妇产科杂志》2025;146(2):285-292)脱垂修复是成年女性最常见的手术之一。绝大多数(80%)接受盆腔器官脱垂修复的患者术后都要服用阿片类药物,对许多患者来说,这是他们第一次接触这些物质。
{"title":"Personalized Prediction of Opioid Demand After Surgery for Pelvic Organ Prolapse: A Randomized Controlled Trial.","authors":"Hope H Bauer, Maura A Schlussel, Emily A Hoffberg, Kasey M Palm, Stephen P Rhodes, Susan D Wherley, Margot Le Neveu, Sarah B Sears, Gabriella M Rustia, Adonis K Hijaz, Sangeeta T Mahajan, Anne G Sammarco, David Sheyn","doi":"10.1097/01.ogx.0001172296.60790.17","DOIUrl":"10.1097/01.ogx.0001172296.60790.17","url":null,"abstract":"<p><p>(Abstracted from Obstet Gynecol 2025;146(2):285-292) Prolapse repair is one of the most common surgeries performed in adult women. An overwhelming majority (80%) of individuals who undergo pelvic organ prolapse repair are prescribed opioids postoperatively, and for many individuals, this is their first exposure to these substances.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"696-697"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Turning the Tide: Recommendations to Increase Cervical Cancer Screening Among Women Who Are Underscreened. 扭转趋势:在未接受筛查的妇女中增加宫颈癌筛查的建议。
IF 3.6 4区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-01 DOI: 10.1097/01.ogx.0001172304.52472.fb
Philippe Descamps, Samantha Dixon, Francesc Xavier Bosch Jose, Maria Kyrgiou, Joseph Monsonego, Ody Neisingh, Lananh Nguyen, Mairead O'Connor, Jennifer S Smith

(Abstracted from Int J Gynaecol Obstet 2024:166 Suppl 1:3-21) The availability of comprehensive health care services and cancer screening in high-income countries has greatly reduced the burden of certain cancers, such as cervical cancer. Although the burden has been significantly reduced, cervical cancer still represents a large health burden with high numbers of deaths attributed to it yearly across the world.

(摘自《国际妇产科杂志》,2014:166,补刊1:3-21)在高收入国家,全面的卫生保健服务和癌症筛查大大减轻了某些癌症(如宫颈癌)的负担。虽然这一负担已大大减轻,但子宫颈癌仍然是一个巨大的健康负担,每年在世界各地造成大量死亡。
{"title":"Turning the Tide: Recommendations to Increase Cervical Cancer Screening Among Women Who Are Underscreened.","authors":"Philippe Descamps, Samantha Dixon, Francesc Xavier Bosch Jose, Maria Kyrgiou, Joseph Monsonego, Ody Neisingh, Lananh Nguyen, Mairead O'Connor, Jennifer S Smith","doi":"10.1097/01.ogx.0001172304.52472.fb","DOIUrl":"https://doi.org/10.1097/01.ogx.0001172304.52472.fb","url":null,"abstract":"<p><p>(Abstracted from Int J Gynaecol Obstet 2024:166 Suppl 1:3-21) The availability of comprehensive health care services and cancer screening in high-income countries has greatly reduced the burden of certain cancers, such as cervical cancer. Although the burden has been significantly reduced, cervical cancer still represents a large health burden with high numbers of deaths attributed to it yearly across the world.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"702-704"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Obstetrical & Gynecological Survey
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1